{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:15:51Z","timestamp":1783206951618,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020869","name":"AstraZeneca Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"School of Medicine, Keio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.03.028","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:59:04Z","timestamp":1779911944000},"page":"62-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential responses of group 2 innate lymphoid cells and TH2 cells to benralizumab in severe asthma"],"prefix":"10.1016","volume":"158","author":[{"given":"Misato","family":"Irie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8853-6149","authenticated-orcid":false,"given":"Hiroki","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kamatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Tagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Hiranuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Gon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Shirasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.jaci.2026.03.028_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Diseases and injuries collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.03.028_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib3","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3390\/cells11172764","article-title":"Current understanding of asthma pathogenesis and biomarkers","volume":"11","author":"Habib","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2026.03.028_bib4","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/all.15054","article-title":"Advances and highlights in asthma in 2021","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.03.028_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imr.12706","article-title":"The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms","volume":"286","author":"Kabata","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.03.028_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cea.12741","article-title":"Elevated levels of circulating CD4+CRTh2+ T cells characterize severe asthma","volume":"46","author":"Palikhe","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.03.028_bib7","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.03.028_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000488050","article-title":"Increased group 2 innate lymphoid cells are correlated with eosinophilic granulocytes in patients with allergic airway inflammation","volume":"176","author":"Yu","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/JAA.S286695","article-title":"In vitro culture with cytokines provides a tool to assess the effector functions of ILC2s in peripheral blood in asthma","volume":"14","author":"Drake","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2026.03.028_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/resp.14506","article-title":"Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics","volume":"28","author":"Malik","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2026.03.028_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacig.2022.07.007","article-title":"Upregulation of IL-4 receptor signaling pathway in circulating ILC2s from asthma patients","volume":"1","author":"Baba","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaci.2026.03.028_bib14","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1038\/srep04736","article-title":"Real-time single-cell imaging of protein secretion","volume":"4","author":"Shirasaki","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.03.028_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-0716-1258-3_28","article-title":"Live-cell imaging technique to visualize DAMPs release during regulated cell death","volume":"2274","author":"Yamagishi","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2026.03.028_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109840","article-title":"Quantitative live-cell imaging of secretion activity reveals dynamic immune responses","volume":"27","author":"Yamagishi","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jaci.2026.03.028_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s42003-023-05297-w","article-title":"Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation","volume":"6","author":"Tanaka","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jaci.2026.03.028_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.alit.2024.10.009","article-title":"Effectiveness of Benralizumab in the Tokyo Asthma Study (TOAST): a real-world prospective interventional trial","volume":"74","author":"Masaki","year":"2025","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.03.028_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaci.2018.01.008","article-title":"Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma","volume":"141","author":"Sehmi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/rccm.202308-1413LE","article-title":"Benralizumab normalizes sputum eosinophilia in severe asthma uncontrolled by anti\u2013IL-5 antibodies: a single-blind, placebo-controlled clinical trial","volume":"208","author":"Mukherjee","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.03.028_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaci.2020.01.038","article-title":"Optimal identification of human conventional and nonconventional (CRTH2\u2212IL7R\u03b1\u2212) ILC2s using additional surface markers","volume":"146","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2024.06.008","article-title":"Comorbid functional dyspepsia reflects IL-33\u2013mediated airway neuronal dysfunction in asthma","volume":"154","author":"Ito","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.03.028_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaci.2023.03.023","article-title":"Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice","volume":"152","author":"LeSuer","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.028_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2014.04.013","article-title":"Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation","volume":"40","author":"Motomura","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.03.028_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cea.13514","article-title":"Blockade of IL-4R\u03b1 inhibits group 2 innate lymphoid cell responses in asthma patients","volume":"50","author":"Patel","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.03.028_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu4913","article-title":"Severe asthma is characterized by a sex-specific ILC landscape and aberrant airway profile that is suppressed by anti\u2013IL-5\/5R\u03b1 biologics","volume":"17","author":"Mincham","year":"2025","journal-title":"Sci Transl Med"},{"issue":"10056","key":"10.1016\/j.jaci.2026.03.028_bib28","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"issue":"10056","key":"10.1016\/j.jaci.2026.03.028_bib29","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti\u2013interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.03.028_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.alit.2022.11.008","article-title":"Biologics for severe asthma: the real-world evidence, effectiveness of switching, and prediction factors for the efficacy","volume":"72","author":"Nagase","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.03.028_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/bloodadvances.2016002352","article-title":"IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells","volume":"1","author":"Camelo","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2026.03.028_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2022.07.003","article-title":"TSLP, IL-33, and IL-25: not just for allergy and helminth infection","volume":"150","author":"Stanbery","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:20:42Z","timestamp":1783203642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926002939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0091674926002939"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.028","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential responses of group 2 innate lymphoid cells and TH2 cells to benralizumab in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}